Literature DB >> 22416209

Intra- and interlaboratory reproducibility of an ELISA serological test for Lyme disease.

M C Tammemagi1, J W Frank, M Leblanc, H Artsob.   

Abstract

OBJECTIVES: Lyme disease has been increasingly diagnosed throughout North America since the late 1970s. The clinical diagnosis and epidemiological monitoring of Lyme disease are aided by serological testing for the etiological agent, Borrelia burgdorferi. Numerous authorities have questioned the reproducibility of these serological tests. This study assessed the intra- and interlaboratory reproducibility of an elisa used to aid in the diagnosis of Lyme disease.
METHODS: Twenty-seven sera from cases and noncases were tested by three laboratories. Two of the laboratories repeated the tests once. These testings were part of the 1991 quality control assessment of provincial laboratories carried out by the Laboratory Centre for Disease Control (lcdc), Ottawa.
RESULTS: The mean weighted kappa statistics were 0.87 for interlaboratory comparisons and 0.89 for intralaboratory comparisons.
CONCLUSIONS: Overall, the elisa assessed in this study demonstrated good to excellent intra- and interlaboratory reproducibility in the lcdc 1991 quality control assessment when the data were assessed in the categorical scale using the weighted kappa statistic. Generalization of these findings to clinical laboratory settings must be done with caution.

Entities:  

Keywords:  ELISA; Lyme borreliosis; Lyme disease; Reliability; Reproducibility; Serology

Year:  1995        PMID: 22416209      PMCID: PMC3298054          DOI: 10.1155/1995/626945

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  25 in total

1.  Consensus conference on Lyme disease.

Authors: 
Journal:  Can J Infect Dis       Date:  1991

2.  High agreement but low kappa: II. Resolving the paradoxes.

Authors:  D V Cicchetti; A R Feinstein
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

3.  Serologic tests for Lyme disease. Interlaboratory variability.

Authors:  S W Luger; E Krauss
Journal:  Arch Intern Med       Date:  1990-04

4.  Intermediate, indeterminate, and uninterpretable diagnostic test results.

Authors:  D L Simel; J R Feussner; E R DeLong; D B Matchar
Journal:  Med Decis Making       Date:  1987 Apr-Jun       Impact factor: 2.583

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Caveats on using nonstandardized serologic tests for Lyme disease.

Authors:  H W Wilkinson; H Russell; J S Sampson
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

7.  Antibody response in Lyme disease: evaluation of diagnostic tests.

Authors:  J E Craft; R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

8.  Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi.

Authors:  L A Magnarelli; J F Anderson
Journal:  Am J Epidemiol       Date:  1988-04       Impact factor: 4.897

9.  The intraclass correlation coefficient as a measure of reliability.

Authors:  J J Bartko
Journal:  Psychol Rep       Date:  1966-08

10.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.